HIV-1 Vpr Functions in Primary CD4+ T Cells
Open Access
Abstract
HIV-1 encodes four accesory proteins in addition to its structural and regulatory genes. Uniquely amongst them, Vpr is abundantly present within virions, meaning it is poised to exert various biological effects on the host cell upon delivery. In this way, Vpr contributes towards the establishment of a successful infection, as evidenced by the extent to which HIV-1 depends on this factor to achieve full pathogenicity in vivo. Although HIV infects various cell types in the host organism, CD4+ T cells are preferentially targeted since they are highly permissive towards productive infection, concomitantly bringing about the hallmark immune dysfunction that accompanies HIV-1 spread. The last several decades have seen unprecedented progress in unraveling the activities Vpr possesses in the host cell at the molecular scale, increasingly underscoring the importance of this viral component. Nevertheless, it remains controversial whether some of these advances bear in vivo relevance, since commonly employed cellular models significantly differ from primary T lymphocytes. One prominent example is the “established” ability of Vpr to induce G2 cell cycle arrest, with enigmatic physiological relevance in infected primary T lymphocytes. The objective of this review is to present these discoveries in their biological context to illustrate the mechanisms whereby Vpr supports HIV-1 infection in CD4+ T cells, whilst identifying findings that require validation in physiologically relevant models.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SCHI1073/7-2, 318213433, SPP1923)
- Open Access Publication Fund of the University of Tübingen (SCHI1073/7-2, 318213433, SPP1923)
This publication has 242 references indexed in Scilit:
- Incidence of autoimmune diseases in people living with HIV compared to a matched population: a cohort studyClinical Rheumatology, 2020
- Evolution of a concept: From accessory protein to key virulence factor, the case of HIV-1 VprBiochemical Pharmacology, 2020
- Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive statusJournal of NeuroVirology, 2016
- HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrestVirologica Sinica, 2015
- Premature Activation of the SLX4 Complex by Vpr Promotes G2/M Arrest and Escape from Innate Immune SensingCell, 2014
- Inhibition of NF‐κB activity by HIV‐1 Vpr is dependent on Vpr binding proteinJournal of Cellular Physiology, 2012
- Nef-Mediated Suppression of T Cell Activation Was Lost in a Lentiviral Lineage that Gave Rise to HIV-1Cell, 2006
- HIV accessory proteins and surviving the host cellCurrent HIV/AIDS Reports, 2004
- Analysis of the HIV-1 LTR NF-κB-Proximal Sp Site III: Evidence for Cell Type-Specific Gene Regulation and Viral ReplicationVirology, 2000
- Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involvedJournal of Molecular Biology, 1998